28 completed, 2 terminated, 1 recruiting, 1 unknown. 21 Phase 1, 6 Phase 2, 6 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 21 | Completed 19, Recruiting 1, Terminated 1 |
| Phase 2 | 6 | Completed 4, Unknown 1, Withdrawn 1 |
| Phase 3 | 6 | Completed 5, Withdrawn 1 |
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow Quinidine: new trials by email Literature Review of Quinidine trials Research Report on Quinidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants NAL ER, Quinidine Sulfate - Healthy Participants | Phase 1 | Recruiting | Trevi Therapeutics | 30 | 2026-11-03 | 2026-11-18 |
| A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants. balcinrenone/ dapagliflozin, quinidine - Healthy Participants | Phase 1 | Completed | AstraZeneca | 14 | 2025-05-20 | 2025-08-12 |
| A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine AZD2389, Quinidine - Advanced Chronic Liver Disease, Healthy Participants | Phase 1 | Completed | AstraZeneca | 16 | 2025-05-12 | 2025-07-25 |
| A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323. EDP-323, Itraconazole, carbamazepine - RSV Infection, Drug Drug Interaction (DDI) | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 48 | 2025-01-27 | 2025-07-01 |
| A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants Orforglipron, Midazolam, Quinidine - Healthy | Phase 1 | Completed | Eli Lilly and Company | 27 | 2024-12-06 | 2026-05-26 |
| A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers NX-5948, Esomeprazole, Placebo - Healthy Volunteer | Phase 1 | Completed | Nurix Therapeutics, Inc. | 223 | 2024-11-30 | 2026-07-28 |
| A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants Repotrectinib, Voriconazole, Quinidine - Healthy Volunteers | Phase 1 | Completed | Bristol-Myers Squibb | 32 | 2024-08-26 | 2025-08-22 |
| A Clinical Trial to Evaluate MK-4208/Embibatinib in Healthy Adult Participants (MK-4208-001/Embibatinib-1014) Embibatinib, Rabeprazole, Midazolam - Healthy | Phase 1 | Completed | Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 196 | 2023-12-21 | 2026-10-22 |
| Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects. EDP-235, Itraconazole, Carbamazepine - COVID-19 | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 36 | 2022-10-06 | 2023-04-27 |
| Quinidine Versus Verapamil in Short-coupled Idiopathic Ventricular Fibrillation Quinidine, Verapamil - Short-coupled Idiopathic Ventricular Fibrillation | Phase 2 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 24 | 2022-10-01 | 2023-09-13 |
| A Study of Imlunestrant (LY3484356) in Female Healthy Participants Imlunestrant, Repaglinide, Omeprazole - Healthy | Phase 1 | Completed | Eli Lilly and Company | 113 | 2022-07-07 | 2025-12-12 |
| Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects EDP-514, Itraconazole, Carbamazepin - Hepatitis B | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 72 | 2020-11-05 | 2021-08-16 |
| Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg), Placebo - Huntington Disease, Irritability | Phase 3 | Completed | The University of Texas Health Science Center, Houston | 20 | 2019-08-05 | 2024-01-05 |
| Impact of Nuedexta on Bulbar Physiology and Function in ALS dextromethorphan HBr and quinidine sulfate - Amyotrophic Lateral Sclerosis | Phase 1 / Phase 2 | Completed | University of Florida | 28 | 2019-07-25 | 2023-03-08 |
| Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects EDP-938, Itraconazole, Rifampin - RSV Infection | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 72 | 2018-11-29 | 2019-06-14 |
| Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers Fluconazole, Quinidine, EDP-305 - NASH - Nonalcoholic Steatohepatitis | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 48 | 2018-07-19 | 2018-12-05 |
| Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants AVP-923 - Healthy Adult Male and Female Volunteers | Phase 1 | Completed | Avanir Pharmaceuticals | 17 | 2017-11-28 | 2018-02-23 |
| Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA) NUEDEXTA® - Pseudobulbar Affect (Involuntary Laughing and/or Crying) | Phase 4 | Terminated | Avanir Pharmaceuticals | 5 | 2015-09-01 | 2017-07-03 |
| Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects Ranolazine, Dofetilide, Verapamil - Drug-induced Surface ECG Changes | Phase 1 | Completed | Food and Drug Administration (FDA) | 22 | 2013-05-01 | 2018-03-08 |
| Clinical Trial Nuedexta in Subjects With ALS Nuedexta, Matching Placebo - Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Completed | Center for Neurologic Study, La Jolla, California, | 90 | 2013-04-01 | 2017-03-24 |
Showing 20 of 33. Sign in to see all of them.
Arrhythmias, Cardiac (4) · Amyotrophic Lateral Sclerosis (3) · Cardiovascular Diseases (3) · Heart Diseases (3) · Atrial Fibrillation (2) · Respiratory Syncytial Virus Infections (2) · Ventricular Fibrillation (2) · Autistic Disorder (1) · Brugada Syndrome (1) · COVID-19 (1) · Death, Sudden, Cardiac (1) · Depressive Disorder, Major (1) · Fasting (1) · Heart Arrest (1) · Hepatitis B (1)
Enanta Pharmaceuticals, Inc (5) · AstraZeneca (3) · Avanir Pharmaceuticals (3) · Eli Lilly and Company (3) · Boehringer Ingelheim (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Biosense Webster, Inc. (1) · Bristol-Myers Squibb (1) · Celgene (1) · Center for Neurologic Study, La Jolla, California, (1) · Food and Drug Administration (FDA) (1) · International Registry of Asymptomatic Brugada Syndrome (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Nurix Therapeutics, Inc. (1) · Sutter Health (1)
United States (24) · Netherlands (2) · Argentina (1) · Brazil (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1) · Kenya (1) · Switzerland (1) · United Kingdom (1)
H. Greene (2) · Adrian Hepner, M.D. (1) · Bo Fransson, MD (1) · Carlos Sanabria, MD (1) · Carol A Parise, PhD (1) · Christian van der Werf, MD PhD (1) · Edward O'Mara, MD (1) · Emily Plowman, PhD (1) · Erin L Furr Stimming, MD (1)
PMID 19029470, PMID 20839238, PMID 22032709, PMID 25054430, PMID 25870186, PMID 26324176, PMID 28036330, PMID 28036334, PMID 28213480, PMID 28974568, PMID 41499296
R01HL031472 (1), R01HL034071 (1)